PINCER BIOTECH’s vision is to treat the untreatable

Pincer_Symbol_edited.png
CEO Dr Charlotte Dyring_edited.png

CEO, Dr Charlotte Dyring

Who we are

We are a privately held, preclinical biotech company, founded in 2019 and located in Aarhus, Denmark.

Our mission is to develop a targeted, safe and effective cure for biomedical implant-associated infections reducing the risk of antimicrobial resistance and saving lives.

We do so by pioneering scientific breakthroughs in close collaboration with leading experts in infectious diseases and vascular implants, and top scientists from industry and academia.